Published in Blood on October 26, 2012
Tax impairs DNA replication forks and increases DNA breaks in specific oncogenic genome regions. Mol Cancer (2014) 0.90
STAT1: A Novel Target of miR-150 and miR-223 Is Involved in the Proliferation of HTLV-I-Transformed and ATL Cells. Neoplasia (2015) 0.87
The need to accessorize: molecular roles of HTLV-1 p30 and HTLV-2 p28 accessory proteins in the viral life cycle. Front Microbiol (2013) 0.85
Tumor Suppressor Inactivation in the Pathogenesis of Adult T-Cell Leukemia. J Oncol (2015) 0.84
miR-28-3p is a cellular restriction factor that inhibits human T cell leukemia virus, type 1 (HTLV-1) replication and virus infection. J Biol Chem (2015) 0.81
Multiple Pathways Control the Reactivation of Telomerase in HTLV-I-Associated Leukemia. Int J Cancer Oncol (2015) 0.75
Increased proteasome activator 28 gamma (PA28γ) levels are unspecific but correlate with disease activity in rheumatoid arthritis. BMC Musculoskelet Disord (2014) 0.75
NOTCH1 Activation Depletes the Pool of Side Population Stem Cells in ATL. J Cancer Sci (2017) 0.75
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A (1980) 30.08
Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A (1982) 12.84
Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A (1984) 4.97
Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer (2007) 4.69
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu Rev Immunol (2000) 4.46
Exporting RNA from the nucleus to the cytoplasm. Nat Rev Mol Cell Biol (2007) 4.12
Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. Virology (1994) 2.14
The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood (2011) 2.11
HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat Med (2004) 1.97
High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J Exp Med (1993) 1.97
Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J Virol (1995) 1.95
Proteasome activator PA28 gamma regulates p53 by enhancing its MDM2-mediated degradation. EMBO J (2008) 1.65
Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo. J Natl Cancer Inst (2001) 1.64
Structure of the proteasome activator REGalpha (PA28alpha). Nature (1997) 1.56
Identification of an activation region in the proteasome activator REGalpha. Proc Natl Acad Sci U S A (1998) 1.54
Immune defects in 28-kDa proteasome activator gamma-deficient mice. J Immunol (2004) 1.46
Human tumor-associated viruses and new insights into the molecular mechanisms of cancer. Oncogene (2008) 1.38
Virions released from cells transfected with a molecular clone of human T-cell leukemia virus type I give rise to primary and secondary infections of T cells. J Virol (1995) 1.37
Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator. J Virol (2004) 1.34
UV-induced fragmentation of Cajal bodies. J Cell Biol (2006) 1.34
Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia. Proc Natl Acad Sci U S A (2010) 1.27
Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention. Cancer Biol Ther (2010) 1.19
Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits. Blood (2010) 1.18
Molecular dissection of the 11S REG (PA28) proteasome activators. Biochimie (2001) 1.06
Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors. Blood (2010) 1.05
Human T-cell lymphotrophic virus type I rex and p30 interactions govern the switch between virus latency and replication. J Biol Chem (2007) 1.05
Establishment of HTLV-I-infected cell lines from French, Guianese and West Indian patients and isolation of a proviral clone producing viral particles. Virus Res (1993) 1.00
Purification procedures determine the proteasome activation properties of REG gamma (PA28 gamma). Arch Biochem Biophys (2004) 0.93
HTLV-I p30 inhibits multiple S phase entry checkpoints, decreases cyclin E-CDK2 interactions and delays cell cycle progression. Mol Cancer (2010) 0.89
Human T-lymphotropic virus type 1 p30 interacts with REGgamma and modulates ATM (ataxia telangiectasia mutated) to promote cell survival. J Biol Chem (2011) 0.88
Human T-lymphotropic type 1 virus p30 inhibits homologous recombination and favors unfaithful DNA repair. Blood (2011) 0.88
The HTLV-1 hbz antisense gene indirectly promotes tax expression via down-regulation of p30(II) mRNA. Virology (2010) 0.85
miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol (2004) 6.44
De novo formation of a subnuclear body. Science (2008) 2.66
Nucleation of nuclear bodies by RNA. Nat Cell Biol (2011) 2.34
HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat Med (2004) 1.97
Liver-specific microRNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cells. J Virol (2008) 1.96
Condensed mitotic chromatin is accessible to transcription factors and chromatin structural proteins. J Cell Biol (2004) 1.86
The moving parts of the nucleolus. Histochem Cell Biol (2005) 1.81
Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. Blood (2009) 1.79
Central role of PI3K in transcriptional activation of hTERT in HTLV-I-infected cells. Blood (2008) 1.61
Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential. Proc Natl Acad Sci U S A (2011) 1.57
The road much traveled: trafficking in the cell nucleus. Curr Opin Cell Biol (2006) 1.52
Rrn3 phosphorylation is a regulatory checkpoint for ribosome biogenesis. J Biol Chem (2002) 1.45
Transgenic expression of cholesterol-7-alpha-hydroxylase prevents atherosclerosis in C57BL/6J mice. Arterioscler Thromb Vasc Biol (2002) 1.39
Seizing of T cells by human T-cell leukemia/lymphoma virus type 1. Adv Cancer Res (2003) 1.38
Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator. J Virol (2004) 1.34
Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence. Blood (2006) 1.33
Transcriptional activation of hTERT through the NF-kappaB pathway in HTLV-I-transformed cells. Blood (2004) 1.32
Aberrant nuclear trafficking of La protein leads to disordered processing of associated precursor tRNAs. Mol Cell (2002) 1.30
JTV1 co-activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress. EMBO J (2011) 1.28
Nucleocytoplasmic shuttling of the retinoblastoma tumor suppressor protein via Cdk phosphorylation-dependent nuclear export. J Biol Chem (2006) 1.28
Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia. Proc Natl Acad Sci U S A (2010) 1.27
Potential roles for ubiquitin and the proteasome during ribosome biogenesis. Mol Cell Biol (2006) 1.25
Regulation of telomerase and telomeres: human tumor viruses take control. J Natl Cancer Inst (2008) 1.24
FBPs are calibrated molecular tools to adjust gene expression. Mol Cell Biol (2006) 1.21
Dynamic force-induced direct dissociation of protein complexes in a nuclear body in living cells. Nat Commun (2012) 1.18
Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits. Blood (2010) 1.18
HTLV-I Tax-dependent and -independent events associated with immortalization of human primary T lymphocytes. Blood (2010) 1.13
Phosphorylation by casein kinase 2 facilitates rRNA gene transcription by promoting dissociation of TIF-IA from elongating RNA polymerase I. Mol Cell Biol (2008) 1.10
Development of a novel system to study hepatitis delta virus genome replication. J Virol (2005) 1.09
Human T-cell lymphotrophic virus type I rex and p30 interactions govern the switch between virus latency and replication. J Biol Chem (2007) 1.05
Resistance of human hepatitis delta virus RNAs to dicer activity. J Virol (2003) 1.04
Histone H2A C-terminus regulates chromatin dynamics, remodeling, and histone H1 binding. PLoS Genet (2010) 1.04
High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins. J Lipid Res (2005) 1.04
Current views on the role of Notch signaling and the pathogenesis of human leukemia. BMC Cancer (2011) 1.03
Histone H1 variant-specific lysine methylation by G9a/KMT1C and Glp1/KMT1D. Epigenetics Chromatin (2010) 1.03
Susceptibility of human hepatitis delta virus RNAs to small interfering RNA action. J Virol (2003) 1.02
Small-interfering RNAs in the radar of the interferon system. Nat Cell Biol (2003) 1.01
The HTLV-I p30 interferes with TLR4 signaling and modulates the release of pro- and anti-inflammatory cytokines from human macrophages. J Biol Chem (2006) 0.99
HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches. Apoptosis (2008) 0.99
Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia. J Exp Med (2010) 0.98
In vivo genetic mutations define predominant functions of the human T-cell leukemia/lymphoma virus p12I protein. Blood (2008) 0.98
SRSF1 regulates the assembly of pre-mRNA processing factors in nuclear speckles. Mol Biol Cell (2012) 0.97
A dual role of linker histone H1.4 Lys 34 acetylation in transcriptional activation. Genes Dev (2012) 0.97
Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T-cell leukemia. Int J Cancer (2006) 0.97
Human T-cell leukemia virus type I p30 nuclear/nucleolar retention is mediated through interactions with RNA and a constituent of the 60 S ribosomal subunit. J Biol Chem (2006) 0.95
Suppression of HTLV-1 replication by Tax-mediated rerouting of the p13 viral protein to nuclear speckles. Blood (2011) 0.94
Isoform-specific phosphorylation of human linker histone H1.4 in mitosis by the kinase Aurora B. J Cell Sci (2011) 0.93
Genome wide analysis of human genes transcriptionally and post-transcriptionally regulated by the HTLV-I protein p30. BMC Genomics (2009) 0.93
Nonphosphorylated human La antigen interacts with nucleolin at nucleolar sites involved in rRNA biogenesis. Mol Cell Biol (2004) 0.92
Evolution of hepatitis delta virus RNA genome following long-term replication in cell culture. J Virol (2005) 0.92
Special article: rescue therapies for acute hypoxemic respiratory failure. Anesth Analg (2010) 0.92
HTLV-I tax increases genetic instability by inducing DNA double strand breaks during DNA replication and switching repair to NHEJ. PLoS One (2012) 0.92
Features affecting the ability of hepatitis delta virus RNAs to initiate RNA-directed RNA synthesis. J Virol (2004) 0.92
Reconstitution in cultured cells of replicating HDV RNA from pairs of less than full-length RNAs. RNA (2004) 0.91
Tax impairs DNA replication forks and increases DNA breaks in specific oncogenic genome regions. Mol Cancer (2014) 0.90
HTLV-I p30 inhibits multiple S phase entry checkpoints, decreases cyclin E-CDK2 interactions and delays cell cycle progression. Mol Cancer (2010) 0.89
Conserved zinc fingers mediate multiple functions of ZFP100, a U7snRNP associated protein. RNA (2006) 0.89
Human T-lymphotropic type 1 virus p30 inhibits homologous recombination and favors unfaithful DNA repair. Blood (2011) 0.88
Overview on HTLV-1 p12, p8, p30, p13: accomplices in persistent infection and viral pathogenesis. Front Microbiol (2012) 0.88
Alternative processing of hepatitis delta virus antigenomic RNA transcripts. J Virol (2004) 0.87
HTLV-1 Yin and Yang: Rex and p30 master regulators of viral mRNA trafficking. AIDS Rev (2008) 0.86
Celecoxib disrupts the canonical apoptotic network in HTLV-I cells through activation of Bax and inhibition of PKB/Akt. Apoptosis (2008) 0.84
HTLV-I p30: a versatile protein modulating virus replication and pathogenesis. Mol Aspects Med (2010) 0.82
Tumor suppressors p53, p63TAα, p63TAy, p73α, and p73β use distinct pathways to repress telomerase expression. J Biol Chem (2012) 0.80
Adult T-cell leukemia cells overexpress Wnt5a and promote osteoclast differentiation. Blood (2013) 0.80
Telomerase: a crucial player in HTLV-I-induced human T-cell leukemia. Cancer Genomics Proteomics (2007) 0.80
In primary effusion lymphoma cells, MYB transcriptional repression is associated with v-FLIP expression during latent KSHV infection while both v-FLIP and v-GPCR become involved during the lytic cycle. Br J Haematol (2007) 0.78
Effects on lipoprotein subclasses of combined expression of human hepatic lipase and human apoB in transgenic rabbits. Arterioscler Thromb Vasc Biol (2003) 0.78
CYP3A4 active site volume modification by mutagenesis of leucine 211. Drug Metab Dispos (2002) 0.78
Association of polymorphisms of STAT6 and SO(2) with Chinese childhood asthma: a case-control study. Biomed Environ Sci (2011) 0.77
Restoration in vivo of defective hepatitis delta virus RNA genomes. RNA (2006) 0.77
Hepatitis delta virus transfection for the mouse in vivo model. Methods Mol Med (2004) 0.75
How to repair and cover a ruptured axillary artery. Plast Reconstr Surg (2009) 0.75